Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2025)
Assembly Biosciences (ASMB) posted quarterly Interest Coverage Ratio of 1.15 for Q4 2025, up 2210.45% year-over-year from 0.05 in Q4 2024, and up 2210.45% quarter-over-quarter from 0.05 in Q4 2024.
Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2025) Analysis & Trends
Assembly Biosciences' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.15 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 2210.45% year-over-year to 1.15; the TTM figure through Dec 2025 stood at 0.7 (down 227.96% YoY), while the FY2025 annual figure was 0.7, down 227.96% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 1.15, up from 0.05 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.15 in Q4 2025, with the low at 23401.0 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 23.11 (2021), against an average of 2221.27.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 1000904.9% in 2022, then jumped 2210.45% in 2025.
- Assembly Biosciences' Interest Coverage Ratio stood at 67.62 in 2021, then soared by 75.23% to 16.75 in 2022, then plunged by 3844.27% to 660.58 in 2023, then jumped by 99.99% to 0.05 in 2024, then surged by 2210.45% to 1.15 in 2025.
- Business Quant data shows ASMB's Interest Coverage Ratio at 1.15 in Q4 2025, 0.05 in Q4 2024, and 660.58 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.15 |
| Dec 31, 2024 | -0.05 |
| Dec 31, 2023 | -660.58 |
| Dec 31, 2022 | -16.75 |
| Sep 30, 2022 | -23,401.00 |
| Jun 30, 2022 | -101.12 |
| Mar 31, 2022 | -142.98 |
| Dec 31, 2021 | -67.62 |
| Sep 30, 2021 | -2.34 |
| Jun 30, 2021 | -23.11 |
| Mar 31, 2021 | -19.57 |
| Dec 31, 2020 | -35.05 |
| Sep 30, 2020 | -0.15 |
| Jun 30, 2020 | 0.10 |
| Mar 31, 2020 | -1.29 |
| Dec 31, 2019 | -26.53 |
| Sep 30, 2019 | -2.89 |
| Jun 30, 2019 | -1.01 |
| Mar 31, 2019 | -27.32 |
| Dec 31, 2018 | -0.30 |